Sophis updates buy-side software

Sophis, a risk management technology vendor based in Paris, has released Value v2.0, a new version of its product for buy-side insitutions.

Sophis says Value handles cash and derivatives equity, fixed income, interest rate and foreign exchange products. Sophis says the new version covers more fixed income and interest rate derivatives, including interest rate swaps, bond floaters, bond futures, interest rate futures and options on interest rate futures. The new version also allows users to automate their reconciliation with administrators and prime brokers, and it adds real-time compliance management.

Value is derived from Sophis' investment banking product, Risque, which it has adapted to handle investment managers' requirements. Sophis says it now offers integrated front office, risk management and connectivity capabilities in a single straight-through–processing system.

Value is currently used by a dozen investment management companies, including AXA, CDC Ixis Asset Management, Astin Capital Management, Maple Leaf Capital and Mail Capital.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here